The generic name of Kanglixin is Kanglixin Capsule. Small cell lung cancer belongs to the category of “lung rock” in Chinese medicine. Kang Lixin Capsule has certain auxiliary therapeutic effect on small cell lung cancer caused by Qi and blood stasis. Kang Lixin Capsule is a Chinese patent medicine, which is composed of Ferula, Chebula, and Mucuna pruriens. It has the efficacy of supporting the positive and dispelling the evil (supporting the positive qi in the body and dispelling the evil qi in the body), and softening and dispersing the hard lumps (softening and dispersing the hard lumps). It has therapeutic effect on digestive tract cancer, breast cancer and lung malignant tumor caused by qi and blood stasis. The adverse effects of Kang Lixin Capsules are not clear at present. Contraindication is prohibited for pregnant women. Precautions are not yet clear. From the efficacy and function of this product, Kang Lixin Capsule can treat lung malignant tumors caused by qi and blood stasis, and also has some therapeutic effect on small cell lung cancer. Before taking this medicine, it is necessary to be guided by a doctor for diagnosis and should not take the medicine by oneself, so as not to cause adverse consequences to the body.